Carter, J., Pugh, S. L., Arring, N., Littell, R. D., Page, S. J., Rowland Jr., K. M., Goodman, J. R., Razaq, W., Siddique, S., Borges, M., Kachnic, L. A., & Barton, D. L. (2024). NRG-CC004 ancillary data study—exploring the effect of bupropion on sexual desire in female cancer survivors with and without vulvovaginal symptoms. The Journal of Sexual Medicine, 21(8), 709–715. https://doi.org/10.1093/jsxmed/qdae061

Lenze, E. J., Mulsant, B. H., Roose, S. P., Lavretsky, H., Reynolds, C. F., Blumberger, D. M., Brown, P. J., Cristancho, P., Flint, A. J., Gebara, M. A., Gettinger, T. R., Lenard, E., Miller, J. P., Nicol, G. E., Oughli, H. A., Pham, V. T., Rollman, B. L., Yang, L., & Karp, J. F. (2023). Antidepressant Augmentation versus Switch in Treatment-Resistant Geriatric Depression. New England Journal of Medicine, 388(12), 1067–1079. https://doi.org/10.1056/nejmoa2204462

Barton, D. L., Pugh, S. L., Ganz, P. A., Plaxe, S. C., Koontz, B. F., Carter, J., Greyz-Yusupov, N., Page, S. J., Rowland, K. M., Balcueva, E. P., Nabeel, S., Basil, J. B., Hill, M. L., Muller, C. Y., Bell, M. C., Deshmukh, S., & Kachnic, L. A. (2022). Randomized Controlled Phase II Evaluation of Two Dose Levels of Bupropion Versus Placebo for Sexual Desire in Female Cancer Survivors: NRG-CC004. Journal of Clinical Oncology, 40(4), 324–334. https://doi.org/10.1200/jco.21.01473